Delivered Revenue of $354 million, up +1% ex-FX, led by Strong Lumbar and Massage Comfort Solutions Growth
Secured $400 million of Automotive New Business Awards including Key Conquest Wins
Commenced Shipment of Customer Approved Production Components from New Morocco Facility
2025 Full Year Revenue Guidance Remains Unchanged, Adjusted EBITDA Margin Range Expanded
NOVI, Mich., April 24, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the first quarter ending March 31, 2025.
“I am pleased with the Gentherm team’s engagement and commitment to driving improved performance throughout the business. Despite the challenging environment, we delivered a first quarter that was in line with our expectations. We made notable progress on positioning the company for future growth by reinvigorating our product lifecycle management, evaluating new market opportunities, and standardizing key processes throughout the company,” said Bill Presley, the Company's President and CEO. “For the year, we have assessed the latest light vehicle production forecasts and the impact of tariffs in effect today. We are maintaining our revenue guidance while slightly adjusting our margin guidance to reflect these expected impacts.”
First Quarter Highlights
Presley concluded, “Despite the near-term disruptions, our priorities remain the same. Our focus is scaling our technology, optimizing our operations, and driving efficiencies. Gentherm has unique capabilities, strong operating momentum, and additional paths for growth. I remain confident in our ability to succeed on these key priorities and drive shareholder value.”
Guidance
The Company’s guidance for full year 2025 is provided below:
Guidance assumes:
The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well reconciliations below to the most directly comparable GAAP financial measures.
Conference Call
As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13753379.
A live webcast and one-year archived replay of the call, as well as a copy of the supplemental materials that will be used during the conference call, can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.
A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on May 8, 2025. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13753379.
Investor Contact
Gregory Blanchette
investors@gentherm.com
248.308.1702
Media Contact
Melissa Fischer
media@gentherm.com
248.289.9702
About Gentherm
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2024, the company recorded annual sales of approximately $1.5 billion and secured $2.4 billion in automotive new business awards. For more information, go to www.gentherm.com.
Forward-Looking Statements
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:
The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.
Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; net capital expenditures (“net CAPEX”); Net Debt, liquidity; net leverage ratio (“net leverage”), revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; and adjusted operating expenses, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as (losses) earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Free Cash Flow as Net cash from operating activities less Purchases of property and equipment. The Company defines net CAPEX as Purchases of property and equipment less Proceeds from the sale of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines liquidity as the sum of cash and cash equivalents and availability under the Company’s revolving line of credit. The Company defines net leverage as Net Debt divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified in the reconciliation tables herein. The Company defines adjusted operating expenses as operating expenses excluding related non-cash stock based compensation, restructuring expenses, net, and other losses not reflective of the Company’s ongoing operations.
The Company’s reconciliations are included in this release or can be found in the supplemental materials on the Company’s website.
In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income (loss), revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.
Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME (Dollars in thousands, except per share data) (Unaudited) |
||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Product revenues | $ | 353,854 | $ | 356,015 | ||||
Cost of sales | 267,389 | 267,262 | ||||||
Gross margin | 86,465 | 88,753 | ||||||
Operating expenses: | ||||||||
Net research and development expenses | 24,216 | 22,745 | ||||||
Selling, general and administrative expenses | 38,478 | 40,721 | ||||||
Restructuring expenses, net | 4,514 | 7,238 | ||||||
Loss on sale of land and building, net | 2,196 | — | ||||||
Total operating expenses | 69,404 | 70,704 | ||||||
Operating income | 17,061 | 18,049 | ||||||
Interest expense, net | (3,555 | ) | (3,244 | ) | ||||
Foreign currency (loss) gain | (10,298 | ) | 2,549 | |||||
Other (loss) income | (1,124 | ) | 973 | |||||
Earnings before income tax | 2,084 | 18,327 | ||||||
Income tax expense | 2,212 | 3,542 | ||||||
Net (loss) income | $ | (128 | ) | $ | 14,785 | |||
Basic (loss) earnings per share | $ | (0.00 | ) | $ | 0.47 | |||
Diluted (loss) earnings per share | $ | (0.00 | ) | $ | 0.47 | |||
Weighted average number of shares – basic | 30,779 | 31,544 | ||||||
Weighted average number of shares – diluted | 30,779 | 31,691 | ||||||
GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited) |
|||||||||||||
Three Months Ended March 31, | |||||||||||||
2025 | 2024 | % Change | |||||||||||
Climate Control Seats (a) | $ | 191,153 | $ | 192,049 | (0.5 | ) | % | ||||||
Climate Control Interiors (a) | 45,341 | 44,398 | 2.1 | % | |||||||||
Lumbar and Massage Comfort Solutions | 45,313 | 38,251 | 18.5 | % | |||||||||
Climate and Comfort Electronics (a) | 7,715 | 4,226 | 82.6 | % | |||||||||
Automotive Climate and Comfort Solutions | 289,522 | 278,924 | 3.8 | % | |||||||||
Valve Systems | 23,173 | 26,625 | (13.0 | ) | % | ||||||||
Other Automotive (a) | 29,179 | 39,089 | (25.4 | ) | % | ||||||||
Subtotal Automotive segment | 341,874 | 344,638 | (0.8 | ) | % | ||||||||
Medical segment | 11,980 | 11,377 | 5.3 | % | |||||||||
Total Company | $ | 353,854 | $ | 356,015 | (0.6 | ) | % | ||||||
Foreign currency translation impact (b) | (5,421 | ) | — | ||||||||||
Total Company, excluding foreign currency translation impact |
$ | 359,275 | $ | 356,015 | 0.9 | % | |||||||
(a) Product categories have been modified, and prior-period amounts have been recast to conform with the current period presentation. Climate Control Seats (CCS) includes CCS Heat (previously Seat Heaters), CCS Vent/CCS Active Cool (previously CCS) and CCS Neck Conditioners (previously included in Other Automotive). Climate Control Interiors (CCI) includes CCI Steering Wheel Heat and CCI Interior Heat (previously included in Other Automotive). Other Automotive includes Automotive Cables, Battery Performance Solutions, non-automotive electronics and contract manufacturing electronics (previously classified as Electronics). | |||||||||||||
(b) Foreign currency translation impacts for the Automotive segment and Medical segment were $(5,352) and $(69) respectively, for the three months ended March 31, 2025. Foreign currency translation impacts for Automotive Climate and Comfort Solutions were $(4,271) for the three months ended March 31, 2025. | |||||||||||||
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited) |
||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Net (loss) income | $ | (128 | ) | $ | 14,785 | |||
Add back: | ||||||||
Depreciation and amortization | 12,788 | 13,580 | ||||||
Income tax expense | 2,212 | 3,542 | ||||||
Interest expense, net (a) | 3,555 | 3,244 | ||||||
Adjustments: | ||||||||
Non-cash stock based compensation (b) | 2,597 | 3,797 | ||||||
Restructuring expenses, net | 4,514 | 7,238 | ||||||
Unrealized currency loss (gain) | 9,607 | (1,856 | ) | |||||
Loss on sale of land and building, net | 2,196 | — | ||||||
Leadership transition expenses | 898 | — | ||||||
Non-automotive electronics inventory benefit | — | (1,060 | ) | |||||
Other (c) | 1,102 | 272 | ||||||
Adjusted EBITDA | $ | 39,341 | $ | 43,542 | ||||
Product revenues | $ | 353,854 | $ | 356,015 | ||||
Net (loss) income margin | (0.0 | )% | 4.2 | % | ||||
Adjusted EBITDA margin | 11.1 | % | 12.2 | % | ||||
(a) Includes $302 of interest expense for the three months ended March 31, 2025, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000. | ||||||||
(b) Includes operating expenses of $2,349 and $3,490 for the three months ended March 31, 2025 and 2024, respectively. | ||||||||
(c) Includes a $1,294 write-down of an equity investment for the three months ended March 31, 2025. | ||||||||
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data) (Unaudited) |
||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Net (loss) income | $ | (128 | ) | $ | 14,785 | |||
Non-cash purchase accounting impact | 1,559 | 1,605 | ||||||
Restructuring expenses, net | 4,514 | 7,238 | ||||||
Unrealized currency loss (gain) | 9,607 | (1,856 | ) | |||||
Loss on sale of land and building, net | 2,196 | — | ||||||
Leadership transition expenses | 898 | — | ||||||
Non-automotive electronics inventory benefit | — | (1,060 | ) | |||||
Other | 1,102 | 272 | ||||||
Tax effect of above | (4,131 | ) | (1,397 | ) | ||||
Adjusted net income | $ | 15,617 | $ | 19,587 | ||||
Weighted average shares outstanding: | ||||||||
Basic | 30,779 | 31,544 | ||||||
Diluted | 30,779 | 31,691 | ||||||
(Loss) earnings per share, as reported: | ||||||||
Basic | $ | (0.00 | ) | $ | 0.47 | |||
Diluted | $ | (0.00 | ) | $ | 0.47 | |||
Adjusted earnings per share: | ||||||||
Basic | $ | 0.51 | $ | 0.62 | ||||
Diluted | $ | 0.51 | $ | 0.62 | ||||
GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in thousands, except share data) (Unaudited) |
||||||||
March 31, 2025 | December 31, 2024 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 163,142 | $ | 134,134 | ||||
Accounts receivable, net | 284,241 | 258,112 | ||||||
Inventory: | ||||||||
Raw materials | 143,275 | 137,511 | ||||||
Work in process | 21,455 | 19,059 | ||||||
Finished goods | 71,258 | 70,786 | ||||||
Inventory, net | 235,988 | 227,356 | ||||||
Other current assets | 80,673 | 64,413 | ||||||
Total current assets | 764,044 | 684,015 | ||||||
Property and equipment, net | 253,169 | 252,970 | ||||||
Goodwill | 102,431 | 99,603 | ||||||
Other intangible assets, net | 56,288 | 57,251 | ||||||
Operating lease right-of-use assets | 57,550 | 43,954 | ||||||
Deferred income tax assets | 75,867 | 75,041 | ||||||
Other non-current assets | 34,897 | 34,722 | ||||||
Total assets | $ | 1,344,246 | $ | 1,247,556 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 243,224 | $ | 226,815 | ||||
Current lease liabilities | 9,535 | 7,517 | ||||||
Current maturities of long-term debt | 138 | 137 | ||||||
Other current liabilities | 100,333 | 105,824 | ||||||
Total current liabilities | 353,230 | 340,293 | ||||||
Long-term debt, less current maturities | 262,034 | 220,064 | ||||||
Non-current lease liabilities | 50,795 | 37,052 | ||||||
Pension benefit obligation | 3,745 | 4,017 | ||||||
Other non-current liabilities | 27,914 | 29,183 | ||||||
Total liabilities | $ | 697,718 | $ | 630,609 | ||||
Shareholders’ equity: | ||||||||
Common Stock: | ||||||||
No par value; 55,000,000 shares authorized 30,859,119 and 30,788,639 issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 3,446 | 2,049 | ||||||
Paid-in capital | 4,290 | 4,290 | ||||||
Accumulated other comprehensive loss | (56,881 | ) | (85,193 | ) | ||||
Accumulated earnings | 695,673 | 695,801 | ||||||
Total shareholders’ equity | 646,528 | 616,947 | ||||||
Total liabilities and shareholders’ equity | $ | 1,344,246 | $ | 1,247,556 | ||||
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited) |
||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Operating Activities: | ||||||||
Net (loss) income | $ | (128 | ) | $ | 14,785 | |||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||||||||
Depreciation and amortization | 12,931 | 13,818 | ||||||
Deferred income taxes | (2,769 | ) | (184 | ) | ||||
Stock based compensation | 2,621 | 3,789 | ||||||
Loss on disposition of property and equipment | 2,338 | 69 | ||||||
Provisions for inventory | 1,427 | 296 | ||||||
Other | 1,082 | (842 | ) | |||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net | (22,597 | ) | (14,856 | ) | ||||
Inventory | (6,141 | ) | (16,648 | ) | ||||
Other assets | (27,312 | ) | (29,226 | ) | ||||
Accounts payable | 14,336 | 12,337 | ||||||
Other liabilities | 10,868 | 6,340 | ||||||
Net cash used in operating activities | (13,344 | ) | (10,322 | ) | ||||
Investing Activities: | ||||||||
Purchases of property and equipment | (14,871 | ) | (11,320 | ) | ||||
Proceeds from the sale of property and equipment | 3,743 | 22 | ||||||
Proceeds from deferred purchase price of factored receivables | 744 | 2,732 | ||||||
Cost of technology investments | (150 | ) | (265 | ) | ||||
Net cash used in investing activities | (10,534 | ) | (8,831 | ) | ||||
Financing Activities: | ||||||||
Borrowings on debt | 52,000 | 10,000 | ||||||
Repayments of debt | (10,037 | ) | (10,324 | ) | ||||
Proceeds from the exercise of Common Stock options | — | 812 | ||||||
Taxes withheld and paid on employees' stock based compensation | (1,224 | ) | (2,022 | ) | ||||
Net cash provided by (used in) financing activities | 40,739 | (1,534 | ) | |||||
Foreign currency effect | 12,147 | (3,879 | ) | |||||
Net increase (decrease) in cash and cash equivalents | 29,008 | (24,566 | ) | |||||
Cash and cash equivalents at beginning of period | 134,134 | 149,673 | ||||||
Cash and cash equivalents at end of period | $ | 163,142 | $ | 125,107 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for taxes | $ | 5,152 | $ | 4,900 | ||||
Cash paid for interest | 3,128 | 3,310 | ||||||
GENTHERM INCORPORATED OTHER NON-GAAP RECONCILIATIONS (Dollars in thousands) (Unaudited) |
||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Total operating expenses | $ | 69,404 | $ | 70,704 | ||||
Restructuring expense, net | (4,514 | ) | (7,238 | ) | ||||
Non-cash stock based compensation | (2,349 | ) | (3,490 | ) | ||||
Leadership transition expenses | (898 | ) | — | |||||
Loss on sale of land and building, net | (2,196 | ) | — | |||||
Other | — | (840 | ) | |||||
Adjusted operating expenses | $ | 59,447 | $ | 59,136 |
March 31, 2025 | March 31, 2024 | |||||||
Cash and cash equivalents | $ | 163,142 | $ | 125,107 | ||||
Revolving line of credit availability | 235,224 | 278,000 | ||||||
Total liquidity | $ | 398,366 | $ | 403,107 | ||||
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。